VEGFA and cancer: In contrast to EphB4 knockdown, knockdown of ephrinB2 reverse signaling on the cancer cell alone demonstrated a small, non-significant decrease in vascular formation (Fig. 5f) and had no effect on endothelial cell proliferation or cell death (Fig. 5g, h) or VEGF levels in vivo (Fig. 5i).